Literature DB >> 24136160

International pediatric liver cancer pathological classification: current trend.

Yukichi Tanaka1, Takeshi Inoue, Hiroshi Horie.   

Abstract

This review describes the pathological classification of pediatric liver cancer types and subtypes proposed at the recent international symposium (March 2011, Los Angeles, USA) and meetings involving pathologists serving as central reviewers for the Children's Oncology Group, Société Internationale d'Oncologie Pédiatrique, Gesellschaft für Pädiatrische Onkologie und Hämatologie, or Japanese Study Group for Pediatric Liver Tumors, and pediatric oncologists/surgeons specializing in liver cancers, as well as immunohistochemical panels, recommendations for submission, sampling and evaluation of diagnostic specimens. The pathological classification is intended to be standardized and clinically meaningful, thus improving future patient management and prognosis. The most common pediatric liver cancer is hepatoblastoma (HBL). HBL has two types, the wholly epithelial type and the mixed epithelial and mesenchymal (MEM) type. The wholly epithelial type was subdivided into well-differentiated fetal (pure fetal with low mitotic activity), crowded fetal (mitotically active), embryonal, epithelial mixed, small cell undifferentiated, and cholangioblastic. A macrotrabecular pattern and a pleomorphic epithelial pattern were recognized as supplemental features of epithelial components. The MEM type was subdivided into MEM without teratoid features and MEM with teratoid features. Other liver cancers in children were divided into hepatocellular carcinoma (classic hepatocellular carcinoma and fibrolamellar carcinoma) and hepatocellular malignant tumor not otherwise specified. This classification is basically applied to pretreatment specimens; the evaluation of post-chemotherapy specimens will be the subject of further studies.

Entities:  

Mesh:

Year:  2013        PMID: 24136160     DOI: 10.1007/s10147-013-0624-8

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  24 in total

1.  Protocol for the examination of specimens from pediatric patients with hepatoblastoma.

Authors:  Milton J Finegold; Dolores H Lopez-Terrada; Jay Bowen; Mary Kay Washington; Stephen J Qualman
Journal:  Arch Pathol Lab Med       Date:  2007-04       Impact factor: 5.534

2.  Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation. A study of 70 cases collected in Japan.

Authors:  M Kasai; I Watanabe
Journal:  Cancer       Date:  1970-03       Impact factor: 6.860

Review 3.  Hepatic tumors in children.

Authors:  J T Stocker
Journal:  Clin Liver Dis       Date:  2001-02       Impact factor: 6.126

4.  Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma.

Authors:  J E Haas; K A Muczynski; M Krailo; A Ablin; V Land; T J Vietti; G D Hammond
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

5.  SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?

Authors:  Pierre Russo; Jaclyn A Biegel
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

6.  Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin.

Authors:  Andrzej Prokurat; Przemysław Kluge; Andrzej Kościesza; Danuta Perek; Andreas Kappeler; Arthur Zimmermann
Journal:  Med Pediatr Oncol       Date:  2002-11

Review 7.  Hepatoblastoma with cholangioblastic features ('cholangioblastic hepatoblastoma') and other liver tumors with bimodal differentiation in young patients.

Authors:  Arthur Zimmermann
Journal:  Med Pediatr Oncol       Date:  2002-11

8.  Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.

Authors:  Samantha Gadd; Simone Treiger Sredni; Chiang-Ching Huang; Elizabeth J Perlman
Journal:  Lab Invest       Date:  2010-03-08       Impact factor: 5.662

9.  Hepatoblastoma. Attempt at characterization of histologic subtypes.

Authors:  F González-Crussi; M P Upton; H S Maurer
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

10.  Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.

Authors:  Rebecka L Meyers; Jon R Rowland; Mark Krailo; Zhengjia Chen; Howard M Katzenstein; Marcio H Malogolowkin
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

View more
  7 in total

Review 1.  2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Anil Arora; Radha K Dhiman; Rakesh Aggarwal; Anil C Anand; Prashant Bhangui; Yogesh K Chawla; Siddhartha Datta Gupta; Vinod K Dixit; Ajay Duseja; Naveen Kalra; Premashish Kar; Suyash S Kulkarni; Rakesh Kumar; Manoj Kumar; Ram Madhavan; V G Mohan Prasad; Amar Mukund; Aabha Nagral; Dipanjan Panda; Shashi B Paul; Padaki N Rao; Mohamed Rela; Manoj K Sahu; Vivek A Saraswat; Samir R Shah; Praveen Sharma; Sunil Taneja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2019-09-23

2.  Integrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma.

Authors:  Manar Atyah; Yi-Rui Yin; Chen-Hao Zhou; Qiang Zhou; Wan-Yong Chen; Qiong-Zhu Dong; Ning Ren
Journal:  Aging (Albany NY)       Date:  2018-08-20       Impact factor: 5.682

3.  Experience of treating pediatric hepatoblastoma at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia - Timely surgical intervention playing a key role.

Authors:  Ibrahim AlFawaz; Basheer Ahmed; Afshan Ali; Mouhab Ayas; Amani AlKofide; Zakaria Habib; Khawar Siddiqui
Journal:  Int J Pediatr Adolesc Med       Date:  2020-11-13

4.  Factors influencing recurrence after complete remission in children with hepatoblastoma: A 14-year retrospective study in China.

Authors:  Fan Li; Weiling Zhang; Huimin Hu; Xia Zhu; Yi Zhang; Dongsheng Huang
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

Review 5.  Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver.

Authors:  Jiliang Feng; Ruidong Zhu; Yu Yin; Shanshan Wang; Lei Zhou; Fudong Lv; Dawei Zhao
Journal:  J Hepatocell Carcinoma       Date:  2021-12-07

6.  Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.

Authors:  Consolato M Sergi
Journal:  Diagnostics (Basel)       Date:  2015-12-30

Review 7.  A Systematic Review and Meta-Analysis of Malignant Rhabdoid and Small Cell Undifferentiated Liver Tumors: A Rational for a Uniform Classification.

Authors:  Juri Fuchs; Anastasia Murtha-Lemekhova; Markus Kessler; Fabian Ruping; Patrick Günther; Alexander Fichtner; Dominik Sturm; Katrin Hoffmann
Journal:  Cancers (Basel)       Date:  2022-01-06       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.